본문 바로가기
KERD
논문KCI 등재

Both sitagliptin analogue & pioglitazone preserve the β-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice

김지원|조재형|김은숙|함동식|윤건호|Chenglin Sun|Jin-A Yeom|Heon-Seok Park
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2011.11|BMB Reports|제44권 제11호|pp. 713-718

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

Type 2 diabetesAkita micedb/db micePioglitazoneSitagliptin analogue
주제분류화학

초록

In this study, the effects of sitagliptin analogue (SITA) or pioglitazone (PIO) treatment on glucose homeostasis and β-cell dynamics in animal models of type 2 diabetes--Akita and db/db mice were evaluated. After 4-6 weeks of treatment, both SITA and PIO were shown to lower non-fasting glucose levels and reduced glycemic excursion in the intraperitoneal glucose tolerance test. In addition, both drugs preserved normal islet structure and the proportion of β-cells in the islets. Compared to the controls, SITA treatment induced a higher β-cell proliferation rate in Akita mice and a lower rate of apoptosis in db/db mice,whereas PIO treatment induced a lower rate of apoptosis in db/db mice and reduced proliferation rates in Akita mice. In conclusion, both SITA and PIO appear to exert some beneficial effects on the islet structure in addition to glycemic control via different mechanisms that involve β-cell dynamics in Akita and db/db mice. [BMB reports 2011; 44(11): 713-718]

Abstract

In this study, the effects of sitagliptin analogue (SITA) or pioglitazone (PIO) treatment on glucose homeostasis and β-cell dynamics in animal models of type 2 diabetes--Akita and db/db mice were evaluated. After 4-6 weeks of treatment, both SITA and PIO were shown to lower non-fasting glucose levels and reduced glycemic excursion in the intraperitoneal glucose tolerance test. In addition, both drugs preserved normal islet structure and the proportion of β-cells in the islets. Compared to the controls, SITA treatment induced a higher β-cell proliferation rate in Akita mice and a lower rate of apoptosis in db/db mice,whereas PIO treatment induced a lower rate of apoptosis in db/db mice and reduced proliferation rates in Akita mice. In conclusion, both SITA and PIO appear to exert some beneficial effects on the islet structure in addition to glycemic control via different mechanisms that involve β-cell dynamics in Akita and db/db mice. [BMB reports 2011; 44(11): 713-718]

참고문헌 (36)

  1. Kahn, S. E, "Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function", Diabetes, 42, pp.1663~1672 (1993)
  2. Bergman, R. N, "Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose", J. Clin. Invest, 68, pp.1456~1457 (1981)
  3. Butler, A. E, "Beta-cell deficit and increased beta- cell apoptosis in humans with type 2 diabetes", Diabetes, 52, pp.102~110 (2003)
  4. UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", Lancet, 352, pp.837~857 (1998)
  5. Montanya, E, "Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy", Diabetes, 49, pp.1341~1346 (2000)
  6. Pospisilik, J. A, "Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin- induced diabetic rats", Diabetes, 52, pp.741~750 (2003)
  7. Mu, J, "Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta- cell mass and function in a rodent model of type 2 diabetes", Diabetes, 55, pp.1695~1704 (2006)
  8. Drucker,D.J, "Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis", Mol. Endocrinol, 17, pp.161~171 (2003)
  9. Nonaka, K, "Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes", Diabetes Res. Clin. Pract, 79, pp.291~298 (2008)
  10. Raz, I, "Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus", Diabetologia, 49, pp.2564~2571 (2006)
  11. Higa, M, "Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats", Proc. Natl. Acad. Sci. U.S.A, 96, pp.11513~11518 (1999)
  12. Finegood, D. T, "Betacell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death", Diabetes, 50, pp.1021~1029 (2001)
  13. Campbell, I. W, "Beta-cell preservation with thiazolidinediones", Diabetes Res. Clin. Pract, 76, pp.163~176 (2007)
  14. Chen, H, "Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db", db mice, 1996, pp.84, 491~495[DOI]
  15. Yoshioka, M, "A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL", 6 (Akita) mutant mice, 1997, pp.46, 887~894
  16. Drucker, D. J, "The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase- 4 inhibitors in type 2 diabetes", Lancet, 368, pp.1696~1705 (2006)
  17. Matveyenko, A. V, "Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin", Diabetes, 58, pp.1604~1615 (2009)
  18. Mu, J, "Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes", Eur. J. Pharmacol, 623, pp.148~154 (2009)
  19. Yki-Jrvinen, H, "Thiazolidinediones", N. Engl. J. Med, 351, pp.1106~1118 (2004)
  20. Robertson, R. P, "Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection", Diabetes, 52, pp.581~587 (2003)
  21. Saitoh, Y, "Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells", Diabetes Obes. Metab, 10, pp.564~573 (2008)
  22. Izumi, T, "Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse", Diabetes, 52, pp.409~416 (2003)
  23. Oyadomari, S, "Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes", J. Clin. Invest, 109, pp.525~532 (2002)
  24. O'Brien, B. A, "Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced", Diabetes, 51, pp.2481~2488 (2002)
  25. Xu, G, "Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats", Diabetes, 48, pp.2270~2276 (1999)
  26. Xu, G, "GLP-1", exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts, 2006, pp.73, 107~110
  27. Kim, S, "Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)", protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression, 2005, pp.280, 22297~22307
  28. Kim, S, "Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2", Mol. Cell. Biol, 28, pp.1644~1656 (2008)
  29. Doyle, M. E, "Mechanisms of action of glucagon-like peptide 1 in the pancreas", Pharmacol. Ther, 113, pp.546~593 (2007)
  30. Friedrichsen, B. N, "Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways", J. Endocrinol, 188, pp.481~492 (2006)
  31. Han, S. J, "Rosiglitazone inhibits early stage of glucolipotoxicity- induced beta-cell apoptosis", Horm. Res, 70, pp.165~173 (2008)
  32. Rhodes, C. J, "Type 2 diabetes-a matter of beta-cell life and death", Science, 307, pp.380~384 (2005)
  33. Bonner-Weir, S, "Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion", Diabetes, 38, pp.49~53 (1989)
  34. Parsons, J. A, "Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion", Endocrinology, 130, pp.1459~1466 (1992)
  35. Kawasaki, F, "Structural and functional analysis of pancreatic islets preserved by pioglitazone in db", db mice, 2005, pp.288, E510~E518
  36. Lamont, B. J, "Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice", Diabetes, 57, pp.190~198 (2008)

관련 논문AI추천

Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice윤형록, 이주미, Kim Gwang Sil, Kim Hyoung Kyu, Nguyen To Hoai T., Pham Trong Kha, Won Jong Chul생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 제 2형 당뇨병 치료제의 개발 동향김익환, 이수현, 이종근한국미생물·생명공학회 · 한국미생물·생명공학회지2012 · 제40권 제3호2형 당뇨병의 새로운 치료고정민대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2009 · 제14권 제1호Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetesAccili Domenico, Son Jinsook생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Lin28a ameliorates glucotoxicity-induced β-cell dysfunction and apoptosis이경민, 전원배, 정권수, Yeo Jin Hwang생화학분자생물학회 · BMB Reports2021 · 제54권 제4호Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes이동윤, 이승아대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2017 · 제22권 제1호

이 간행물의 다른 논문 (10건)

An electrochemical functional assay for the sensing of nitric oxide release induced by angiogenic factorsRaphaël Trouillon, Danny O’Hare, Soo-Ik Changpp. 699-704Recent advances in microfluidic technologies for biochemistry and molecular biology조숭원, 주재범, 장수익, 강동구, Andrew J. deMellopp. 705-712Molecular cloning and sequence and 3D models analysis of the Sec61α subunit of protein translocation complex from Penicillium ochrochloronMd. Asraful Jahan, Hitoshi Shibata, Yoshihiro Sawa, Takahiro Ishikawa, Md. Mahbub Hasan, Abul Kalam Azadpp. 719-724Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinomaSehwa Kim, 김솔잎, Chang Seok Ki, Kyoung Mee Kim, Myoung-Gun Lee, Jae-Moon Bae, Jong-Won Kimpp. 725-729Protective effects of a chalcone derivative against Aβ-induced oxidative stress and neuronal damageYoo-Hyun Lee, Mi-Jeong Kim, 나영화, 윤호근, 곽지은pp. 730-734
원문 보기